-
Genetically modified viral injection could treat metastatic melanoma
europeanpharmaceuticalreview
January 29, 2019
A study has reported that almost 40 percent of patients with non-surgically treatable tumours were effectively treated using a genetically modified virus…
-
Lupin Pharmaceuticals Issues Voluntary Recall of Ceftriaxone for Injection
americanpharmaceuticalreview
January 10, 2019
Lupin Pharmaceuticals is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, 1g and 3 lots of Ceftriaxone for Injection .....
-
Athenex Pharmaceutical Launches Levothyroxine Sodium for Injection
americanpharmaceuticalreview
December 28, 2018
Athenex announced the launch of Levothyroxine Sodium for Injection through its subsidiary Athenex Pharmaceutical Division (APD). The APD product was brought to market in close cooperation with Princeton....
-
Cadila Healthcare arm gets USFDA nod for ulcer treatment injection
expressbpd
December 12, 2018
Cadila Healthcare said the product will be manufactured at Liva Pharma’s manufacturing facility at Vadodara
-
CASI Pharmaceuticals Announces China Market Approval Of Melphalan Hydrochloride For Injection
firstwordpharma
December 04, 2018
CASI Pharmaceuticals Executive Chairman Wei-Wu He, Ph.D., commented, "NMPA approval of Melphalan Hydrochloride For Injection (EVOMELA®) is encouraging news for patients in China with multiple myeloma as there is no commercially available melphalan formula
-
FDA approves treatment for peripheral T-cell lymphoma
europeanpharmaceuticalreview
November 20, 2018
The US Food and Drug Administration has approved first-line treatment for newly diagnosed peripheral T-cell lymphoma using a new review program…
-
FDA to Review Eylea Injection
americanpharmaceuticalreview
September 14, 2018
Regeneron Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License Application (sBLA) of Eylea (aflibercept) Injection for the treatment of diabetic retinopathy (DR), the leading caus
-
Mylan Launches Generic Brevibloc Injection in Single-Dose Bags
americanpharmaceuticalreview
September 14, 2018
Mylan announced the U.S. launch of Esmolol Hydrochloride in Sodium Chloride Injection, 2,500 mg/250 mL (10 mg/mL) Single-Dose Plastic Bag and 2,000 mg/100 mL (20 mg/mL) Single-Dose Plastic Bag, the first generic version of Brevibloc.
-
DRL launches generic Azacitidine for Injection in Canada
expressbpd
November 06, 2017
Dr Reddy’s Laboratories (DRL) announced that generic Azacitidine for injection 100 mg/vial, a bioequivalent generic version of VIDAZA (azacitidine for injection), is approved by Health Canada.
-
Long-acting injection to remove daily dosing burden for HIV patients?
cphi-online
July 26, 2017
Study results showed that long-acting cabotegravir and rilpivirine maintained viral suppression.